NNM Securities

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC

BSE2065.40-14.4 (-0.69 %)

PREV CLOSE ( ) 2079.80

OPEN PRICE ( ) 2080.40

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 14837

TODAY'S LOW / HIGH ( )2039.75 2118.00

52 WK LOW / HIGH ( )1228 2649.95

NSE2065.60-11.65 (-0.56 %)

PREV CLOSE( ) 2077.25

OPEN PRICE ( ) 2078.00

BID PRICE (QTY) 2065.60 (111)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 190449

TODAY'S LOW / HIGH( ) 2041.00 2118.00

52 WK LOW / HIGH ( )1227 2524

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 13-11 1924

Management Info

R S Karnad - Chairman Bhushan Akshikar - Managing Director

Registered Office

Address Gsk House, Dr. Annie Besant Road,Worli,,
Mumbai,
Maharashtra-400030

Phone 022-24959595

Email in.investorquery@gsk.com

Website www.gsk-india.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE, MCX

NEWS

24Apr GlaxoSmithKline Pharmaceuticals inform
Pursuant to Regulation 39 and other application regulations of SEBI (Lis..

16Apr GlaxoSmithKline Pharmaceuticals inform
Pursuant to Regulation 39 and other application regulations of SEBI (Lis..

05Apr GlaxoSmithKline Pharmaceuticals inform
Pursuant to Regulation 39 and other application regulations of SEBI (Lis..

04Apr Glaxosmithkline Pharmaceuticals inform
Pursuant to Regulation 39 and other application regulations of SEBI (Lis..

02Apr Glaxosmithkline Pharmaceuticals inform
In Compliance with Regulation 74(5) of SEBI (Depositories and Participan..

Financials

Rs. in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	454.900000000001	6077.5
Gross Profit	651.100000000001	8323.8
Operating Profit	2458.5	9009.3
Net Sales	8049.8	32163.4

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr. Reddy's Lab (BSE) 6217.15 (4.47%)	M.Cap (Rs. in Cr)103713.42
Abbott India (BSE) 25725.00 (1.03%)	M.Cap (Rs. in Cr)54663.83
Bharat Parenterals (BSE) 1701.80 (10.00%)	M.Cap (Rs. in Cr)990.39
Alkem Laboratories (BSE) 4857.90 (3.10%)	M.Cap (Rs. in Cr)58083.48
NGL Fine-Chem (BSE) 2711.85 (3.47%)	M.Cap (Rs. in Cr)1675.39

Shareholding Pattern

	PROMOTERS	75%
	NON-INSTITUTION	13.62%
	MUTUAL FUNDS/UTI	4.51%
	FI/BANKS/INSURANCE	3.27%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Quant Healthcare Fu...	3.39
Aditya Birla SL MNC...	3.02
Nippon India Pharma...	2.33
Quant Large & Mid C...	2.08
DSP Nifty Midcap 15...	1.83
UTI Nifty Midcap 15...	1.83
DSP Nifty Midcap 15...	1.83

ATTENTION INVESTORSKYCIPO

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :

Assamese	Bengali	Gujrati	Hindi	Kanada
Kashmiri	Konkani	Malyalam	Marathi	Oriya
Punjabi	Sindhi	Tamil	Telegu	Urdu

REGISTRATION NOS.

Filing compliant on SCORES – Easy & quick

Register on SCORES portal
Mandatory details for filing complaints on SCORES:
- Name
- PAN
- Address
- Mobile Number
- E-mail ID
Benefits:
- i.) Effective communication
- ii.) Speedy redressal of the grievances

SMART ODR Portal

INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

NNM Securities

Smart Quotes

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

Filing compliant on SCORES – Easy & quick